N/A N=240 Randomized Prevention

Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya

Cryptosporidium; Diarrhea · Cryptosporidiosis · Communicable Diseases · Diarrheal Disease

Bottom Line

View on ClinicalTrials.gov: NCT01695304 ↗

Enrolled (actual)

240

Serious AEs

0.0%

Results posted

Mar 2017

Primary outcome: Primary: Longitudinal Diarrhea Prevalence — 7.6; 8.9 Incidence rate per 100 person-weeks

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Ceramic water filter (Other)
Age: Pediatric · 0+ yrs
Sex: All
Sponsor: Centers for Disease Control and Prevention
Primary completion: Aug 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Longitudinal Diarrhea Prevalence	7.6; 8.9	—
PRIMARY Health Facility Visits for Diarrheal Disease	1.2; 2.2	—

Summary

The aim of the study is to examine the efficacy of ceramic water filters to reduce the burden of waterborne diarrheal illness among infants in selected villages in Kenya. In Kenya very young children are given drinking water or water is used in reconstitution of their food. We hypothesize that ceramic water filters will remove Cryptosporidium from drinking water reducing infection in infants.

Eligibility Criteria

Inclusion Criteria

Children 4-10 months old living in selected villages in the Asembo Health and Demographic Surveillance System (HDSS) study area in Kenya whose primary caretakers consent on their behalf to be visited weekly for 6 months to carry out weekly illness surveillance, and have a follow up home visit one year after initial enrollment into the trial. The household in which the child resides must be a consenting participant in the HDSS. As the children included in the trial are infants, the child's primary caretaker will be invited to participate and be administered questionnaires. Random selection will be at the compound level. Only one household per compound will be eligible for selection.

Exclusion Criteria

Children 4-10 months old whose households are not active consenting participants in the HDSS will not be eligible for inclusion. Only the subset of children 4-10 months old who are randomly selected in the sample will be eligible for participation.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01695304). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.